Association between visceral fat area and metabolic syndrome in individuals with normal body weight: insights from a Chinese health screening dataset
Background Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor. However, the relationship between visceral fat area (VFA) and MetS within this population remains inadequately explored, and the diagnostic th...
Saved in:
Published in | Lipids in health and disease Vol. 24; no. 1; pp. 57 - 13 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
18.02.2025
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1476-511X 1476-511X |
DOI | 10.1186/s12944-025-02482-0 |
Cover
Abstract | Background
Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor. However, the relationship between visceral fat area (VFA) and MetS within this population remains inadequately explored, and the diagnostic threshold for MetS in normal-weight individuals is yet to be established.
Methods
This study used a cross-sectional design combined with longitudinal cohort analysis. Data were collected from 5,944 normal-weight participants who underwent health screenings at Henan Provincial People’s Hospital of China between October 2018 and October 2024. VFA was measured via multislice computed tomography scanning, and VFA-based tertile categorization was applied among the participants. The relationship between VFA and MetS was examined using univariate and multivariate logistic regression analyses. Nonlinear relationship was investigated by restricted cubic spline (RCS) modeling, and diagnostic accuracy was determined by receiver operating characteristic (ROC) curve analysis. Furthermore, data from individuals who completed three or more screenings were used to construct Kaplan–Meier survival curves for MetS events, with significance tested using the log-rank method.
Results
Among the individuals with a normal BMI, elevated VFA was associated with a high incidence of MetS. After the adjustment for confounders, VFA was significantly associated with MetS risk [odds ratio (OR) = 1.13, 95% confidence interval (CI): 1.12–1.25]. The subjects in the highest VFA tertile showed significantly elevated MetS risk (OR = 30.33; 95% CI: 19.00–48.43,
P
< 0.001) versus those in the lowest tertile. The RCS model demonstrated a nonlinear, positive association between VFA and MetS risk (
P
for nonlinearity < 0.001), with risk escalation slowing down when the VFA exceeded 100 cm². ROC analysis showed that VFA had the highest diagnostic accuracy for MetS compared with other abdominal fat measures (AUC = 0.844, sensitivity = 0.839, specificity = 0.793, and accuracy = 0.785). In a longitudinal subset of 398 normal-weight participants followed for 6 years, 106 MetS cases occurred, with cumulative incidence rising as VFA increased (log-rank test,
P
< 0.001).
Conclusion
VFA shows an independent, nonlinear, positive association with MetS risk among normal-weight individuals, with a threshold effect at 100 cm². VFA = 162.85 cm² may serve as an accurate and effective predictor for MetS in this population. |
---|---|
AbstractList | Background Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor. However, the relationship between visceral fat area (VFA) and MetS within this population remains inadequately explored, and the diagnostic threshold for MetS in normal-weight individuals is yet to be established. Methods This study used a cross-sectional design combined with longitudinal cohort analysis. Data were collected from 5,944 normal-weight participants who underwent health screenings at Henan Provincial People's Hospital of China between October 2018 and October 2024. VFA was measured via multislice computed tomography scanning, and VFA-based tertile categorization was applied among the participants. The relationship between VFA and MetS was examined using univariate and multivariate logistic regression analyses. Nonlinear relationship was investigated by restricted cubic spline (RCS) modeling, and diagnostic accuracy was determined by receiver operating characteristic (ROC) curve analysis. Furthermore, data from individuals who completed three or more screenings were used to construct Kaplan-Meier survival curves for MetS events, with significance tested using the log-rank method. Results Among the individuals with a normal BMI, elevated VFA was associated with a high incidence of MetS. After the adjustment for confounders, VFA was significantly associated with MetS risk [odds ratio (OR) = 1.13, 95% confidence interval (CI): 1.12-1.25]. The subjects in the highest VFA tertile showed significantly elevated MetS risk (OR = 30.33; 95% CI: 19.00-48.43, P < 0.001) versus those in the lowest tertile. The RCS model demonstrated a nonlinear, positive association between VFA and MetS risk (P for nonlinearity < 0.001), with risk escalation slowing down when the VFA exceeded 100 cm². ROC analysis showed that VFA had the highest diagnostic accuracy for MetS compared with other abdominal fat measures (AUC = 0.844, sensitivity = 0.839, specificity = 0.793, and accuracy = 0.785). In a longitudinal subset of 398 normal-weight participants followed for 6 years, 106 MetS cases occurred, with cumulative incidence rising as VFA increased (log-rank test, P < 0.001). Conclusion VFA shows an independent, nonlinear, positive association with MetS risk among normal-weight individuals, with a threshold effect at 100 cm². VFA = 162.85 cm² may serve as an accurate and effective predictor for MetS in this population. Keywords: Intra-abdominal fat, Metabolic syndrome, Body mass index, Asian continental ancestry group Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor. However, the relationship between visceral fat area (VFA) and MetS within this population remains inadequately explored, and the diagnostic threshold for MetS in normal-weight individuals is yet to be established.BACKGROUNDMetabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor. However, the relationship between visceral fat area (VFA) and MetS within this population remains inadequately explored, and the diagnostic threshold for MetS in normal-weight individuals is yet to be established.This study used a cross-sectional design combined with longitudinal cohort analysis. Data were collected from 5,944 normal-weight participants who underwent health screenings at Henan Provincial People's Hospital of China between October 2018 and October 2024. VFA was measured via multislice computed tomography scanning, and VFA-based tertile categorization was applied among the participants. The relationship between VFA and MetS was examined using univariate and multivariate logistic regression analyses. Nonlinear relationship was investigated by restricted cubic spline (RCS) modeling, and diagnostic accuracy was determined by receiver operating characteristic (ROC) curve analysis. Furthermore, data from individuals who completed three or more screenings were used to construct Kaplan-Meier survival curves for MetS events, with significance tested using the log-rank method.METHODSThis study used a cross-sectional design combined with longitudinal cohort analysis. Data were collected from 5,944 normal-weight participants who underwent health screenings at Henan Provincial People's Hospital of China between October 2018 and October 2024. VFA was measured via multislice computed tomography scanning, and VFA-based tertile categorization was applied among the participants. The relationship between VFA and MetS was examined using univariate and multivariate logistic regression analyses. Nonlinear relationship was investigated by restricted cubic spline (RCS) modeling, and diagnostic accuracy was determined by receiver operating characteristic (ROC) curve analysis. Furthermore, data from individuals who completed three or more screenings were used to construct Kaplan-Meier survival curves for MetS events, with significance tested using the log-rank method.Among the individuals with a normal BMI, elevated VFA was associated with a high incidence of MetS. After the adjustment for confounders, VFA was significantly associated with MetS risk [odds ratio (OR) = 1.13, 95% confidence interval (CI): 1.12-1.25]. The subjects in the highest VFA tertile showed significantly elevated MetS risk (OR = 30.33; 95% CI: 19.00-48.43, P < 0.001) versus those in the lowest tertile. The RCS model demonstrated a nonlinear, positive association between VFA and MetS risk (P for nonlinearity < 0.001), with risk escalation slowing down when the VFA exceeded 100 cm². ROC analysis showed that VFA had the highest diagnostic accuracy for MetS compared with other abdominal fat measures (AUC = 0.844, sensitivity = 0.839, specificity = 0.793, and accuracy = 0.785). In a longitudinal subset of 398 normal-weight participants followed for 6 years, 106 MetS cases occurred, with cumulative incidence rising as VFA increased (log-rank test, P < 0.001).RESULTSAmong the individuals with a normal BMI, elevated VFA was associated with a high incidence of MetS. After the adjustment for confounders, VFA was significantly associated with MetS risk [odds ratio (OR) = 1.13, 95% confidence interval (CI): 1.12-1.25]. The subjects in the highest VFA tertile showed significantly elevated MetS risk (OR = 30.33; 95% CI: 19.00-48.43, P < 0.001) versus those in the lowest tertile. The RCS model demonstrated a nonlinear, positive association between VFA and MetS risk (P for nonlinearity < 0.001), with risk escalation slowing down when the VFA exceeded 100 cm². ROC analysis showed that VFA had the highest diagnostic accuracy for MetS compared with other abdominal fat measures (AUC = 0.844, sensitivity = 0.839, specificity = 0.793, and accuracy = 0.785). In a longitudinal subset of 398 normal-weight participants followed for 6 years, 106 MetS cases occurred, with cumulative incidence rising as VFA increased (log-rank test, P < 0.001).VFA shows an independent, nonlinear, positive association with MetS risk among normal-weight individuals, with a threshold effect at 100 cm². VFA = 162.85 cm² may serve as an accurate and effective predictor for MetS in this population.CONCLUSIONVFA shows an independent, nonlinear, positive association with MetS risk among normal-weight individuals, with a threshold effect at 100 cm². VFA = 162.85 cm² may serve as an accurate and effective predictor for MetS in this population. Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor. However, the relationship between visceral fat area (VFA) and MetS within this population remains inadequately explored, and the diagnostic threshold for MetS in normal-weight individuals is yet to be established. This study used a cross-sectional design combined with longitudinal cohort analysis. Data were collected from 5,944 normal-weight participants who underwent health screenings at Henan Provincial People's Hospital of China between October 2018 and October 2024. VFA was measured via multislice computed tomography scanning, and VFA-based tertile categorization was applied among the participants. The relationship between VFA and MetS was examined using univariate and multivariate logistic regression analyses. Nonlinear relationship was investigated by restricted cubic spline (RCS) modeling, and diagnostic accuracy was determined by receiver operating characteristic (ROC) curve analysis. Furthermore, data from individuals who completed three or more screenings were used to construct Kaplan-Meier survival curves for MetS events, with significance tested using the log-rank method. Among the individuals with a normal BMI, elevated VFA was associated with a high incidence of MetS. After the adjustment for confounders, VFA was significantly associated with MetS risk [odds ratio (OR) = 1.13, 95% confidence interval (CI): 1.12-1.25]. The subjects in the highest VFA tertile showed significantly elevated MetS risk (OR = 30.33; 95% CI: 19.00-48.43, P < 0.001) versus those in the lowest tertile. The RCS model demonstrated a nonlinear, positive association between VFA and MetS risk (P for nonlinearity < 0.001), with risk escalation slowing down when the VFA exceeded 100 cm². ROC analysis showed that VFA had the highest diagnostic accuracy for MetS compared with other abdominal fat measures (AUC = 0.844, sensitivity = 0.839, specificity = 0.793, and accuracy = 0.785). In a longitudinal subset of 398 normal-weight participants followed for 6 years, 106 MetS cases occurred, with cumulative incidence rising as VFA increased (log-rank test, P < 0.001). VFA shows an independent, nonlinear, positive association with MetS risk among normal-weight individuals, with a threshold effect at 100 cm². VFA = 162.85 cm² may serve as an accurate and effective predictor for MetS in this population. Abstract Background Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor. However, the relationship between visceral fat area (VFA) and MetS within this population remains inadequately explored, and the diagnostic threshold for MetS in normal-weight individuals is yet to be established. Methods This study used a cross-sectional design combined with longitudinal cohort analysis. Data were collected from 5,944 normal-weight participants who underwent health screenings at Henan Provincial People’s Hospital of China between October 2018 and October 2024. VFA was measured via multislice computed tomography scanning, and VFA-based tertile categorization was applied among the participants. The relationship between VFA and MetS was examined using univariate and multivariate logistic regression analyses. Nonlinear relationship was investigated by restricted cubic spline (RCS) modeling, and diagnostic accuracy was determined by receiver operating characteristic (ROC) curve analysis. Furthermore, data from individuals who completed three or more screenings were used to construct Kaplan–Meier survival curves for MetS events, with significance tested using the log-rank method. Results Among the individuals with a normal BMI, elevated VFA was associated with a high incidence of MetS. After the adjustment for confounders, VFA was significantly associated with MetS risk [odds ratio (OR) = 1.13, 95% confidence interval (CI): 1.12–1.25]. The subjects in the highest VFA tertile showed significantly elevated MetS risk (OR = 30.33; 95% CI: 19.00–48.43, P < 0.001) versus those in the lowest tertile. The RCS model demonstrated a nonlinear, positive association between VFA and MetS risk (P for nonlinearity < 0.001), with risk escalation slowing down when the VFA exceeded 100 cm². ROC analysis showed that VFA had the highest diagnostic accuracy for MetS compared with other abdominal fat measures (AUC = 0.844, sensitivity = 0.839, specificity = 0.793, and accuracy = 0.785). In a longitudinal subset of 398 normal-weight participants followed for 6 years, 106 MetS cases occurred, with cumulative incidence rising as VFA increased (log-rank test, P < 0.001). Conclusion VFA shows an independent, nonlinear, positive association with MetS risk among normal-weight individuals, with a threshold effect at 100 cm². VFA = 162.85 cm² may serve as an accurate and effective predictor for MetS in this population. Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor. However, the relationship between visceral fat area (VFA) and MetS within this population remains inadequately explored, and the diagnostic threshold for MetS in normal-weight individuals is yet to be established. This study used a cross-sectional design combined with longitudinal cohort analysis. Data were collected from 5,944 normal-weight participants who underwent health screenings at Henan Provincial People's Hospital of China between October 2018 and October 2024. VFA was measured via multislice computed tomography scanning, and VFA-based tertile categorization was applied among the participants. The relationship between VFA and MetS was examined using univariate and multivariate logistic regression analyses. Nonlinear relationship was investigated by restricted cubic spline (RCS) modeling, and diagnostic accuracy was determined by receiver operating characteristic (ROC) curve analysis. Furthermore, data from individuals who completed three or more screenings were used to construct Kaplan-Meier survival curves for MetS events, with significance tested using the log-rank method. Among the individuals with a normal BMI, elevated VFA was associated with a high incidence of MetS. After the adjustment for confounders, VFA was significantly associated with MetS risk [odds ratio (OR) = 1.13, 95% confidence interval (CI): 1.12-1.25]. The subjects in the highest VFA tertile showed significantly elevated MetS risk (OR = 30.33; 95% CI: 19.00-48.43, P < 0.001) versus those in the lowest tertile. The RCS model demonstrated a nonlinear, positive association between VFA and MetS risk (P for nonlinearity < 0.001), with risk escalation slowing down when the VFA exceeded 100 cm². ROC analysis showed that VFA had the highest diagnostic accuracy for MetS compared with other abdominal fat measures (AUC = 0.844, sensitivity = 0.839, specificity = 0.793, and accuracy = 0.785). In a longitudinal subset of 398 normal-weight participants followed for 6 years, 106 MetS cases occurred, with cumulative incidence rising as VFA increased (log-rank test, P < 0.001). VFA shows an independent, nonlinear, positive association with MetS risk among normal-weight individuals, with a threshold effect at 100 cm². VFA = 162.85 cm² may serve as an accurate and effective predictor for MetS in this population. Background Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor. However, the relationship between visceral fat area (VFA) and MetS within this population remains inadequately explored, and the diagnostic threshold for MetS in normal-weight individuals is yet to be established. Methods This study used a cross-sectional design combined with longitudinal cohort analysis. Data were collected from 5,944 normal-weight participants who underwent health screenings at Henan Provincial People’s Hospital of China between October 2018 and October 2024. VFA was measured via multislice computed tomography scanning, and VFA-based tertile categorization was applied among the participants. The relationship between VFA and MetS was examined using univariate and multivariate logistic regression analyses. Nonlinear relationship was investigated by restricted cubic spline (RCS) modeling, and diagnostic accuracy was determined by receiver operating characteristic (ROC) curve analysis. Furthermore, data from individuals who completed three or more screenings were used to construct Kaplan–Meier survival curves for MetS events, with significance tested using the log-rank method. Results Among the individuals with a normal BMI, elevated VFA was associated with a high incidence of MetS. After the adjustment for confounders, VFA was significantly associated with MetS risk [odds ratio (OR) = 1.13, 95% confidence interval (CI): 1.12–1.25]. The subjects in the highest VFA tertile showed significantly elevated MetS risk (OR = 30.33; 95% CI: 19.00–48.43, P < 0.001) versus those in the lowest tertile. The RCS model demonstrated a nonlinear, positive association between VFA and MetS risk ( P for nonlinearity < 0.001), with risk escalation slowing down when the VFA exceeded 100 cm². ROC analysis showed that VFA had the highest diagnostic accuracy for MetS compared with other abdominal fat measures (AUC = 0.844, sensitivity = 0.839, specificity = 0.793, and accuracy = 0.785). In a longitudinal subset of 398 normal-weight participants followed for 6 years, 106 MetS cases occurred, with cumulative incidence rising as VFA increased (log-rank test, P < 0.001). Conclusion VFA shows an independent, nonlinear, positive association with MetS risk among normal-weight individuals, with a threshold effect at 100 cm². VFA = 162.85 cm² may serve as an accurate and effective predictor for MetS in this population. |
ArticleNumber | 57 |
Audience | Academic |
Author | Lin, Xinbei Sun, Yongbing Zou, Zhi Li, Hao Guo, Zhiping Ji, Xiaoqi Li, Xin Wang, Yong Liu, Ao Li, Tao Li, Yongli Zhou, Yang Du, Yawei Li, Zhonglin Wu, Xiaoling Lv, Xue Zhang, Jiancheng |
Author_xml | – sequence: 1 givenname: Yongbing surname: Sun fullname: Sun, Yongbing organization: Department of Medical Imaging, Zhengzhou University People’s Hospital, Henan Provincial People’s Hospital – sequence: 2 givenname: Xinbei surname: Lin fullname: Lin, Xinbei organization: Department of Medical Imaging, Zhengzhou University People’s Hospital, Henan Provincial People’s Hospital – sequence: 3 givenname: Zhi surname: Zou fullname: Zou, Zhi organization: Department of Medical Imaging, Zhengzhou University People’s Hospital, Henan Provincial People’s Hospital – sequence: 4 givenname: Yang surname: Zhou fullname: Zhou, Yang organization: Department of Medical Imaging, Zhengzhou University People’s Hospital, Henan Provincial People’s Hospital – sequence: 5 givenname: Ao surname: Liu fullname: Liu, Ao organization: Department of Medical Imaging, Zhengzhou University People’s Hospital, Henan Provincial People’s Hospital – sequence: 6 givenname: Xin surname: Li fullname: Li, Xin organization: Department of Medical Imaging, Henan University People’s Hospital, Henan Provincial People’s Hospital – sequence: 7 givenname: Yawei surname: Du fullname: Du, Yawei organization: Department of Medical Imaging, Henan University People’s Hospital, Henan Provincial People’s Hospital – sequence: 8 givenname: Xiaoqi surname: Ji fullname: Ji, Xiaoqi organization: Department of Medical Imaging, Zhengzhou University People’s Hospital, Henan Provincial People’s Hospital – sequence: 9 givenname: Zhonglin surname: Li fullname: Li, Zhonglin organization: Department of Medical Imaging, Zhengzhou University People’s Hospital, Henan Provincial People’s Hospital – sequence: 10 givenname: Xiaoling surname: Wu fullname: Wu, Xiaoling organization: Department of Nuclear Medicine, Henan Provincial People’s Hospital – sequence: 11 givenname: Yong surname: Wang fullname: Wang, Yong organization: Henan Provincial People’s Hospital – sequence: 12 givenname: Xue surname: Lv fullname: Lv, Xue organization: Henan Provincial People’s Hospital – sequence: 13 givenname: Tao surname: Li fullname: Li, Tao organization: Chronic Health Management Laboratory, Fuwai Central China Cardiovascular Hospital – sequence: 14 givenname: Jiancheng surname: Zhang fullname: Zhang, Jiancheng organization: Department of Gastrointestinal Surgery, Henan Provincial People’s Hospital – sequence: 15 givenname: Zhiping surname: Guo fullname: Guo, Zhiping organization: Chronic Health Management Laboratory, Fuwai Central China Cardiovascular Hospital – sequence: 16 givenname: Hao surname: Li fullname: Li, Hao email: leehao2004@163.com organization: Chronic Health Management Laboratory, Fuwai Central China Cardiovascular Hospital – sequence: 17 givenname: Yongli surname: Li fullname: Li, Yongli email: shyliyongli@126.com organization: Department of Health Management, Henan Provincial People’s Hospital, Chronic Health Management Laboratory, Zhengzhou University People’s Hospital |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39966964$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ksuK2zAUhk2Z0rm0L9BFEXTTjaeSrch2NyWEXgYGummhO3EsHTsKtjSVnIQ8SN-3J-PpMIFSLCMhff-vy_kvszMfPGbZa8GvhajV-ySKRsqcFwv6ZV3k_Fl2IWSl8oUQP8-ejM-zy5Q2nBe8UupFdl42jVKNkhfZ72VKwTiYXPCsxWmP6NnOJYMRBtbBxCAiMPCWjThBGwZnWDp4G8OIzHlq1u2c3cKQ2N5Na-ZDHEnaBntge3T9evpAUDoOEutIxoCt1s5jQrZGGEiSTKRtne-ZhQkSTi-z5x0Z4quH_ir78fnT99XX_Pbbl5vV8jY3i1JMuSjLtqk4B2lMqQpuVSdQCNtURjTcWivqWhblomsbKEqUsiqsbUABKiNN3ZVX2c3sawNs9F10I8SDDuD0_USIvYY4OTOgppfDYiFqW9lKtp1orVJtBy3WdQ2KA3l9nL3utu2I1qCf6AlPTE9XvFvrPuw01bKslFyQw7sHhxh-bTFNejwWYhjAY9gmXQpVl42oZEPo2xntgc7mfBfI0hxxvayLmiotuSLq-h8UfRZHZyhMnaP5E8Gbp3d4PPzfvBBQzICJIaWI3SMi-PEiSs-h1BRKfR9KzUlUzqJEsO8x6k3YRk-F_Z_qD2pv5rE |
Cites_doi | 10.2337/diacare.26.3.650 10.3904/kjim.2018.427 10.1210/clinem/dgad152 10.1155/2013/378632 10.1016/j.tem.2008.10.006 10.1155/2013/393192 10.1038/nrdp.2017.34 10.1136/bmjopen-2016-013831 10.3390/nu5041218 10.1016/j.metabol.2020.154456 10.1161/CIRCULATIONAHA.106.675355 10.1291/hypres.31.1283 10.1111/cpf.12700 10.1152/ajpregu.00653.2001 10.1111/jdi.13306 10.1074/jbc.M300423200 10.1007/s11154-013-9252-x 10.1016/j.ebiom.2018.10.025 10.1074/jbc.M210689200 10.1093/ajcn/79.3.379 10.3390/nu11061430 10.1136/bmjopen-2020-048221 10.1016/j.pcad.2018.07.003 10.1155/2012/584541 10.7326/0003-4819-145-4-200608150-00004 10.1016/j.clnu.2019.07.012 10.1186/s12933-023-01765-z 10.1038/s41572-024-00563-5 10.3389/fpubh.2023.1073824 10.3390/nu5030928 10.1002/advs.202103719 10.1016/j.dsx.2017.03.006 10.1111/joim.13355 10.1002/cac2.12393 10.3389/fendo.2024.1411678 10.1016/j.cmet.2023.01.006 10.1038/s41591-024-03095-3 10.4082/kjfm.17.0099 10.1016/j.dsx.2022.102584 10.1159/000520418 10.3390/ijerph16214152 10.4082/kjfm.18.0122 10.1016/j.jcmg.2014.07.017 10.1111/dme.14060 10.18544/PEDM-23.02.0079 10.3346/jkms.2011.26.7.906 10.1007/s11906-018-0812-z 10.2147/DMSO.S483497 10.1111/obr.13767 10.3109/07853890.2010.526138 10.1016/j.orcp.2017.10.005 10.1016/S2213-8587(23)00086-4 10.1259/bjr/38447238 |
ContentType | Journal Article |
Copyright | The Author(s) 2025 2025. The Author(s). COPYRIGHT 2025 BioMed Central Ltd. The Author(s) 2025 2025 |
Copyright_xml | – notice: The Author(s) 2025 – notice: 2025. The Author(s). – notice: COPYRIGHT 2025 BioMed Central Ltd. – notice: The Author(s) 2025 2025 |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.1186/s12944-025-02482-0 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Full Text |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1476-511X |
EndPage | 13 |
ExternalDocumentID | oai_doaj_org_article_076e2518d7d74bf1bd66bfabe888a60a PMC11837645 A828002406 39966964 10_1186_s12944_025_02482_0 |
Genre | Journal Article |
GeographicLocations | China Japan |
GeographicLocations_xml | – name: China – name: Japan |
GrantInformation_xml | – fundername: Medical Science and Technology Research Project of Henan Province grantid: SBGJ202402100; LHGJ20230074 – fundername: Central Plains Science and Technology Innovation leading talent Program grantid: 244200510016 – fundername: Key scientific research project of Henan University grantid: 25A310026 – fundername: Henan Provincial Science and Technology Tackling Program Project Funding grantid: 242102311121; 222102310283 – fundername: National Key Research and Development Program of China grantid: 2022YFC2010001 funderid: http://dx.doi.org/10.13039/501100012166 – fundername: Independent Innovation Project of Zhengzhou University grantid: ZC20240105 – fundername: Key Science and Technology Projects of Henan Province grantid: 241100310300 – fundername: National Key Research and Development Program of China grantid: 2022YFC2010001 |
GroupedDBID | --- 0R~ 29L 2WC 53G 5GY 5VS 7X7 88E 8FE 8FH 8FI 8FJ A8Z AAFWJ AAHBH AAJSJ AASML ABDBF ABUWG ACGFO ACGFS ACPRK ACUHS ADBBV ADRAZ ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CS3 DIK E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESTFP ESX F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IGS IHR INH INR ITC KQ8 LK8 M1P M7P M~E O5R O5S OK1 OVT P2P P6G PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM PMFND 7X8 5PM |
ID | FETCH-LOGICAL-c531t-133b9700a4cc3620d6f1e11d97c190ddd1884235fb9a23e4472dd9a6ae6c4c8f3 |
IEDL.DBID | DOA |
ISSN | 1476-511X |
IngestDate | Wed Aug 27 01:30:18 EDT 2025 Thu Aug 21 18:28:39 EDT 2025 Mon Sep 08 14:52:28 EDT 2025 Tue Jun 17 21:59:24 EDT 2025 Tue Jun 10 20:57:50 EDT 2025 Sat May 10 01:40:59 EDT 2025 Tue Jul 01 05:42:15 EDT 2025 Sat Sep 06 07:34:19 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Intra-abdominal fat Body mass index Asian continental ancestry group Metabolic syndrome |
Language | English |
License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c531t-133b9700a4cc3620d6f1e11d97c190ddd1884235fb9a23e4472dd9a6ae6c4c8f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doaj.org/article/076e2518d7d74bf1bd66bfabe888a60a |
PMID | 39966964 |
PQID | 3168391749 |
PQPubID | 23479 |
PageCount | 13 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_076e2518d7d74bf1bd66bfabe888a60a pubmedcentral_primary_oai_pubmedcentral_nih_gov_11837645 proquest_miscellaneous_3168391749 gale_infotracmisc_A828002406 gale_infotracacademiconefile_A828002406 pubmed_primary_39966964 crossref_primary_10_1186_s12944_025_02482_0 springer_journals_10_1186_s12944_025_02482_0 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2025-02-18 |
PublicationDateYYYYMMDD | 2025-02-18 |
PublicationDate_xml | – month: 02 year: 2025 text: 2025-02-18 day: 18 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Lipids in health and disease |
PublicationTitleAbbrev | Lipids Health Dis |
PublicationTitleAlternate | Lipids Health Dis |
PublicationYear | 2025 |
Publisher | BioMed Central BioMed Central Ltd BMC |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
References | RN Bergman (2482_CR39) 2006; 14 J Ye (2482_CR7) 2023; 108 B Klop (2482_CR40) 2013; 5 J Gui (2482_CR5) 2023; 11 Q Zeng (2482_CR23) 2021; 115 N Stefan (2482_CR3) 2023; 11 I Dichi (2482_CR30) 2012; 2012 B Muhlhausler (2482_CR35) 2009; 20 M Katahira (2482_CR53) 2022; 16 2482_CR38 CM Phillips (2482_CR12) 2013; 14 RM Sandsdal (2482_CR6) 2023; 22 HH Jeon (2482_CR19) 2021; 36 L Huo (2482_CR24) 2019; 36 Y Tatsumi (2482_CR18) 2017; 7 BF Zhou (2482_CR21) 2002; 15 D Nikolic (2482_CR43) 2013; 5 JP Bennett (2482_CR47) 2024; 25 A Hiuge-Shimizu (2482_CR48) 2012; 44 R Feng (2482_CR17) 2023; 43 MG Saklayen (2482_CR4) 2018; 20 P González-Muniesa (2482_CR11) 2017; 3 C Torun (2482_CR51) 2024; 15 GJ Brewer (2482_CR14) 2021; 41 N Stefan (2482_CR42) 2023; 7 2482_CR28 IJ Neeland (2482_CR1) 2024; 10 LM Pammer (2482_CR2) 2021; 290 T Tchkonia (2482_CR34) 2002; 282 D Nagayama (2482_CR16) 2022; 15 RV Shah (2482_CR52) 2014; 7 A Lee (2482_CR54) 2018; 39 Z Xu (2482_CR15) 2021; 11 H Zand (2482_CR36) 2017; 11 H Nishizawa (2482_CR10) 2019; 11 CS Fox (2482_CR29) 2007; 116 L Busetto (2482_CR9) 2024; 30 H Duan (2482_CR45) 2022; 9 OY Bello-Chavolla (2482_CR50) 2020; 39 T Hayashi (2482_CR56) 2003; 26 HI Kim (2482_CR46) 2011; 26 I Janssen (2482_CR13) 2004; 79 AS Levey (2482_CR22) 2006; 145 B Wang (2482_CR8) 2018; 12 Z Gao (2482_CR32) 2003; 278 N Stefan (2482_CR41) 2024; 13 A Shuster (2482_CR55) 2012; 85 J Wu (2482_CR20) 2024; 17 V Rakotoarivelo (2482_CR31) 2018; 37 JJ Senn (2482_CR33) 2003; 278 E Araki (2482_CR49) 2020; 11 L Wang (2482_CR25) 2013; 2013 YH Lee (2482_CR44) 2020; 41 A Elagizi (2482_CR26) 2018; 61 E Oda (2482_CR37) 2008; 31 Z Zdrojewicz (2482_CR27) 2017; 23 |
References_xml | – volume: 26 start-page: 650 year: 2003 ident: 2482_CR56 publication-title: Diabetes Care doi: 10.2337/diacare.26.3.650 – volume: 36 start-page: 97 year: 2021 ident: 2482_CR19 publication-title: Korean J Intern Med doi: 10.3904/kjim.2018.427 – volume: 108 start-page: 2240 year: 2023 ident: 2482_CR7 publication-title: J Clin Endocrinol Metab doi: 10.1210/clinem/dgad152 – volume: 2013 start-page: 378632 year: 2013 ident: 2482_CR25 publication-title: Int J Endocrinol doi: 10.1155/2013/378632 – volume: 20 start-page: 51 year: 2009 ident: 2482_CR35 publication-title: Trends Endocrinol Metab doi: 10.1016/j.tem.2008.10.006 – ident: 2482_CR38 doi: 10.1155/2013/393192 – volume: 3 start-page: 17034 year: 2017 ident: 2482_CR11 publication-title: Nat Rev Dis Primers doi: 10.1038/nrdp.2017.34 – volume: 7 start-page: e013831 year: 2017 ident: 2482_CR18 publication-title: BMJ Open doi: 10.1136/bmjopen-2016-013831 – volume: 15 start-page: 83 year: 2002 ident: 2482_CR21 publication-title: Biomed Environ Sci – volume: 5 start-page: 1218 year: 2013 ident: 2482_CR40 publication-title: Nutrients doi: 10.3390/nu5041218 – volume: 115 start-page: 154456 year: 2021 ident: 2482_CR23 publication-title: Metabolism doi: 10.1016/j.metabol.2020.154456 – volume: 116 start-page: 39 year: 2007 ident: 2482_CR29 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.675355 – volume: 31 start-page: 1283 year: 2008 ident: 2482_CR37 publication-title: Hypertens Res doi: 10.1291/hypres.31.1283 – volume: 41 start-page: 317 year: 2021 ident: 2482_CR14 publication-title: Clin Physiol Funct Imaging doi: 10.1111/cpf.12700 – volume: 282 start-page: R1286 year: 2002 ident: 2482_CR34 publication-title: Am J Physiol Regul Integr Comp Physiol doi: 10.1152/ajpregu.00653.2001 – volume: 11 start-page: 1020 year: 2020 ident: 2482_CR49 publication-title: J Diabetes Investig doi: 10.1111/jdi.13306 – volume: 278 start-page: 24944 issue: 27 year: 2003 ident: 2482_CR32 publication-title: J Biol Chem doi: 10.1074/jbc.M300423200 – volume: 14 start-page: 219 year: 2013 ident: 2482_CR12 publication-title: Rev Endocr Metab Disord doi: 10.1007/s11154-013-9252-x – volume: 37 start-page: 564 year: 2018 ident: 2482_CR31 publication-title: EBioMedicine doi: 10.1016/j.ebiom.2018.10.025 – volume: 278 start-page: 13740 issue: 16 year: 2003 ident: 2482_CR33 publication-title: J Biol Chem doi: 10.1074/jbc.M210689200 – volume: 79 start-page: 379 year: 2004 ident: 2482_CR13 publication-title: Am J Clin Nutr doi: 10.1093/ajcn/79.3.379 – volume: 11 start-page: 1430 year: 2019 ident: 2482_CR10 publication-title: Nutrients doi: 10.3390/nu11061430 – volume: 11 start-page: e048221 year: 2021 ident: 2482_CR15 publication-title: BMJ Open doi: 10.1136/bmjopen-2020-048221 – volume: 61 start-page: 142 year: 2018 ident: 2482_CR26 publication-title: Prog Cardiovasc Dis doi: 10.1016/j.pcad.2018.07.003 – volume: 2012 start-page: 584541 year: 2012 ident: 2482_CR30 publication-title: J Nutr Metab doi: 10.1155/2012/584541 – volume: 145 start-page: 247 year: 2006 ident: 2482_CR22 publication-title: Ann Intern Med doi: 10.7326/0003-4819-145-4-200608150-00004 – volume: 39 start-page: 1613 year: 2020 ident: 2482_CR50 publication-title: Clin Nutr doi: 10.1016/j.clnu.2019.07.012 – volume: 22 start-page: 41 year: 2023 ident: 2482_CR6 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-023-01765-z – volume: 10 start-page: 77 year: 2024 ident: 2482_CR1 publication-title: Nat Rev Dis Primers doi: 10.1038/s41572-024-00563-5 – volume: 11 start-page: 1073824 year: 2023 ident: 2482_CR5 publication-title: Front Public Health doi: 10.3389/fpubh.2023.1073824 – volume: 5 start-page: 928 year: 2013 ident: 2482_CR43 publication-title: Nutrients doi: 10.3390/nu5030928 – volume: 9 start-page: e2103719 year: 2022 ident: 2482_CR45 publication-title: Adv Sci (Weinh) doi: 10.1002/advs.202103719 – volume: 11 start-page: S307 issue: Suppl 1 year: 2017 ident: 2482_CR36 publication-title: Diabetes Metab Syndr doi: 10.1016/j.dsx.2017.03.006 – volume: 290 start-page: 1219 year: 2021 ident: 2482_CR2 publication-title: J Intern Med doi: 10.1111/joim.13355 – volume: 43 start-page: 75 year: 2023 ident: 2482_CR17 publication-title: Cancer Commun (Lond) doi: 10.1002/cac2.12393 – volume: 15 start-page: 1411678 year: 2024 ident: 2482_CR51 publication-title: Front Endocrinol (Lausanne) doi: 10.3389/fendo.2024.1411678 – volume: 14 start-page: s16 issue: Suppl 1 year: 2006 ident: 2482_CR39 publication-title: Obes (Silver Spring) – volume: 7 start-page: 236 issue: 2 year: 2023 ident: 2482_CR42 publication-title: Cell Metab doi: 10.1016/j.cmet.2023.01.006 – volume: 30 start-page: 2395 year: 2024 ident: 2482_CR9 publication-title: Nat Med doi: 10.1038/s41591-024-03095-3 – volume: 39 start-page: 239 year: 2018 ident: 2482_CR54 publication-title: Korean J Fam Med doi: 10.4082/kjfm.17.0099 – volume: 16 start-page: 102584 year: 2022 ident: 2482_CR53 publication-title: Diabetes Metab Syndr doi: 10.1016/j.dsx.2022.102584 – volume: 15 start-page: 160 year: 2022 ident: 2482_CR16 publication-title: Obes Facts doi: 10.1159/000520418 – ident: 2482_CR28 doi: 10.3390/ijerph16214152 – volume: 41 start-page: 229 year: 2020 ident: 2482_CR44 publication-title: Korean J Fam Med doi: 10.4082/kjfm.18.0122 – volume: 7 start-page: 1221 year: 2014 ident: 2482_CR52 publication-title: JACC Cardiovasc Imaging doi: 10.1016/j.jcmg.2014.07.017 – volume: 36 start-page: 1268 year: 2019 ident: 2482_CR24 publication-title: Diabet Med doi: 10.1111/dme.14060 – volume: 23 start-page: 96 year: 2017 ident: 2482_CR27 publication-title: Pediatr Endocrinol Diabetes Metab doi: 10.18544/PEDM-23.02.0079 – volume: 26 start-page: 906 year: 2011 ident: 2482_CR46 publication-title: J Korean Med Sci doi: 10.3346/jkms.2011.26.7.906 – volume: 20 start-page: 12 year: 2018 ident: 2482_CR4 publication-title: Curr Hypertens Rep doi: 10.1007/s11906-018-0812-z – volume: 17 start-page: 3509 year: 2024 ident: 2482_CR20 publication-title: Diabetes Metab Syndr Obes doi: 10.2147/DMSO.S483497 – volume: 13 start-page: S2213 year: 2024 ident: 2482_CR41 publication-title: Lancet Diabetes Endocrinol – volume: 25 start-page: e13767 year: 2024 ident: 2482_CR47 publication-title: Obes Rev doi: 10.1111/obr.13767 – volume: 44 start-page: 82 year: 2012 ident: 2482_CR48 publication-title: Ann Med doi: 10.3109/07853890.2010.526138 – volume: 12 start-page: 61 year: 2018 ident: 2482_CR8 publication-title: Obes Res Clin Pract doi: 10.1016/j.orcp.2017.10.005 – volume: 11 start-page: 426 year: 2023 ident: 2482_CR3 publication-title: Lancet Diabetes Endocrinol doi: 10.1016/S2213-8587(23)00086-4 – volume: 85 start-page: 1 year: 2012 ident: 2482_CR55 publication-title: Br J Radiol doi: 10.1259/bjr/38447238 |
SSID | ssj0020766 |
Score | 2.4066148 |
Snippet | Background
Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor.... Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor. However, the... Background Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk factor.... Abstract Background Metabolic syndrome (MetS) is increasingly diagnosed in individuals with normal body weight, and visceral fat emerges as a significant risk... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 57 |
SubjectTerms | Adipose tissues Adult Aged Analysis Asian continental ancestry group Biomedical and Life Sciences Body Mass Index Body Weight Care and treatment China - epidemiology Clinical Nutrition Cross-Sectional Studies CT imaging Diagnosis Female Health aspects Humans Intra-abdominal fat Intra-Abdominal Fat - diagnostic imaging Intra-Abdominal Fat - pathology Life Sciences Lipidology Longitudinal Studies Male Medical Biochemistry Medical screening Metabolic diseases Metabolic syndrome Metabolic Syndrome - diagnosis Metabolic Syndrome - diagnostic imaging Metabolic Syndrome - epidemiology Metabolic Syndrome - pathology Methods Middle Aged Risk Factors ROC Curve |
SummonAdditionalLinks | – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9VAEF6kgvgi2nqJVhlB9EGD2WSzyfp2PFiKUJ8s9G3ZWzDQ5hSTKv0h_l9nNsnhpIrgW8huSLJz3535hrFXAk2S8UGkzpVFKjzqQYt-f6pU7n1huXARZ_bkizw-FZ_PyrMJJodqYXbP73kt3_doj4RIqekqoW_lKYbnt0tUvJS-t5brbXCF8bici2L--tzC8ER8_j-18I4ZupkieeOcNJqfo_vs3uQ3wmok9AN2K3T77GDVYcx8cQ2vIWZyxi3yfXbnZDowP2C_dpYfppws-NH2jraioDEDGPQawXQeLsKADHHeOphRDKDtoN0WbPVAe7bQkZN7Dnbjr-Fn3Ff9gJN6uuiBilXAADXlDn2AscgSUDPha_G3gPJR-zA8ZKdHn76uj9OpE0OKFOTUr76wqsoyI5xDi5d52fDAuVeVQ4fCe8_rGv2ysrHK5EUQokJKKyNNkE64uikesb1u04UnDFwp8hC4UZmRwjprqdLOECxgI7xQVcLezmTSlyPgho6BSi31SFSNRNWRqDpL2Eei5HYmgWXHG8hDepI9jawR0I2rfeUrYRtuvZS2MTZg9G9kZhL2hvhAk0gjsZ2ZKhPwgwkcS68wKo1YcDJhh4uZKIpuMfxy5iRNQ5S_1oXNVa-pPViBkbFQCXs8ctb2mwsKOZUUCasXPLf4qeVI136LSOC4KmggRJmwdzN76kkH9f9Ytaf_N_0Zu5uPgpTy-pDtDd-vwnN0xQb7Isrgb_0LLbU priority: 102 providerName: Springer Nature |
Title | Association between visceral fat area and metabolic syndrome in individuals with normal body weight: insights from a Chinese health screening dataset |
URI | https://link.springer.com/article/10.1186/s12944-025-02482-0 https://www.ncbi.nlm.nih.gov/pubmed/39966964 https://www.proquest.com/docview/3168391749 https://pubmed.ncbi.nlm.nih.gov/PMC11837645 https://doaj.org/article/076e2518d7d74bf1bd66bfabe888a60a |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVFSB databaseName: Free Full-Text Journals in Chemistry customDbUrl: eissn: 1476-511X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020766 issn: 1476-511X databaseCode: HH5 dateStart: 20020101 isFulltext: true titleUrlDefault: http://abc-chemistry.org/ providerName: ABC ChemistRy – providerCode: PRVADU databaseName: BioMed Central_OA刊 customDbUrl: eissn: 1476-511X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020766 issn: 1476-511X databaseCode: RBZ dateStart: 20020101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1476-511X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020766 issn: 1476-511X databaseCode: KQ8 dateStart: 20020101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1476-511X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020766 issn: 1476-511X databaseCode: KQ8 dateStart: 20020901 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1476-511X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020766 issn: 1476-511X databaseCode: DOA dateStart: 20020101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1476-511X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020766 issn: 1476-511X databaseCode: ABDBF dateStart: 20020101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1476-511X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020766 issn: 1476-511X databaseCode: DIK dateStart: 20020101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1476-511X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020766 issn: 1476-511X databaseCode: GX1 dateStart: 20020101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1476-511X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020766 issn: 1476-511X databaseCode: M~E dateStart: 20020101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central (ODIN) customDbUrl: eissn: 1476-511X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020766 issn: 1476-511X databaseCode: RPM dateStart: 20020101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1476-511X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020766 issn: 1476-511X databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1476-511X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020766 issn: 1476-511X databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVAVX databaseName: Springer Nature HAS Fully OA customDbUrl: eissn: 1476-511X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020766 issn: 1476-511X databaseCode: AAJSJ dateStart: 20021201 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: Springer Nature OA Free Journals customDbUrl: eissn: 1476-511X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020766 issn: 1476-511X databaseCode: C6C dateStart: 20021201 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1476-511X dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0020766 issn: 1476-511X databaseCode: U2A dateStart: 20021201 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9RAEB-0gvgi2voRrccIog8amo-9TeLb9WgpQouIB_e27FfoQZsTc1X6h_j_OrNJyqWCvvhy5G433GZ_szszm5nfALwRpJK08yK2dprHwtE-aMjuj6sqcy43qbCBZ_b0TJ4sxKfldLlV6otjwjp64G7iDsjP9qSDS1e4Qpg6NU5KU2vjyXXTMgmmEamxwZnqXS26Sw4pMqU8aEmrCRFz6Vbm8MriZKSGAlv_n3vyllK6HTB5661pUEbHj-Bhb0XirBv9Y7jjm13YmzXkQV9e41sMcZ3hwHwX7p_2r8_34NcWGNhHaOGPVWv5YAprvUFNNiTqxuGl35B4XKwsDpwGuGpwdZO-1SKf4GLDJu8FmrW7xp_hlPUjdWr5okVOXUGNXKLbtx67lEukfYr-lh4LOTq19ZsnsDg--jo_ifu6DDHhmXL1-txURZJoYS3pv8TJOvVp6qrCknnhnEvLkqy0aW0qneVeiIJwr7TUXlphyzp_CjvNuvHPAe1UZN6nukq0FMYaw3l3mkkCa-FEVUTwfoBJfevoN1RwW0qpOlAVgaoCqCqJ4JCRvOnJ1NnhBxIo1QuU-pdARfCO5UDxAiewre7zFGjATJWlZuSjBmY4GcH-qCctTDtqfj1IkuImjmZr_PqqVVwsLCc_WVQRPOsk62bMOTuglRQRlCOZGz3UuKVZnQdecJoVUhdiGsGHQTxVvyO1f5m1F_9j1l7Cg6xbXnFa7sPO5vuVf0Xm2sZM4G6xLCZw7_Do7PMX-jaX80lYrfS5yGa_AfsyQo0 |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6hrQRcELQ8AgUGCcEBoiYbx3G4LYhqWbq90Eq9WX4FIrVZ1GxB_SH8X8ZOsmoKQuIWrb3K45vxzNgz3wC8ZGSSlHUsNibPYmZpHdTk98dlObU20ykzgWd2ecjnx2xxkp_0RWHtkO0-HEmGlTqoteB7LVkmxmLfftXzcE1jCtS3RJ5zNoGt2WzxZbEJtCg250OBzF__OTJCgav_zxX5ikm6ni557cw0mKL9u3Cn9yFx1oF-D264Zht2Zg3Fz2eX-ApDVmfYLt-Gm8v-8HwHfl2BAvv8LPxRt8ZvS2Gl1qjIg0TVWDxzaxKO09rgwGiAdYP1pnirRb9_i413eE9Rr-wl_gx7rO9oUusvWvSFK6jQN-h2rcOu4BJplaLb0muhz01t3fo-HO9_PPowj_uuDDGhmfre9ZkuiyRRzBiyfonlVerS1JaFIefCWpsKQT5aXulSTTPHWEGol4orxw0zosoewKRZNe4RoMnZ1LlUlYniTButfdWd8hSBFbOsLCJ4M8Akv3fkGzIELYLLDlRJoMoAqkwieO-R3Mz0xNnhh9X5V9nroSTRcOTSCVvYgukq1ZZzXSnthBCKJyqC114OpFdvAtuovkqBHtgTZckZRaiBF45HsDuaSWppRsMvBkmSfsjnsjVuddFK3yosoyiZlRE87CRr88yZDz9LziIQI5kbvdR4pKm_BVZw-ipkLFgewdtBPGW_HrX_-GqP_2_6c7g1P1oeyINPh5-fwO1pp1RxKnZhsj6_cE_JRVvrZ71G_gZmlzYW |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEF-kheKLaOtHtOoIog8amlw2m41v58dRT1sELfRt2a_UgzZXmlTpH-L_68wmOS5VBN_C7R75mN_szOzO_Iax5xxNknaex9bmWcwdroMG_f64LCfOZSblNvDMHhyK_SM-P86P16r4Q7b7cCTZ1TQQS1Pd7p27qlNxKfYatFKcx9SKlTi5JjEG7ZsyLwWGX5vT6fzrfBV0YZwuhmKZv_5zZJACb_-fq_OaebqeOnnt_DSYpdltdqv3J2HaAeAOu-HrbbYzrTGWPruCFxAyPMPW-TbbOugP0nfYrzWxQJ-rBT8WjaUtKqh0Cxq9SdC1gzPfIlBOFxYGdgNY1LBYFXI1QHu5UJPzewpm6a7gZ9hvfYOTGrpogIpYQAM16_aNh674EnDFwtviawHlqTa-vcuOZh--vduP-w4NMUo2pT72mSmLJNHcWrSEiRNV6tPUlYVFR8M5l0qJ_lpemVJPMs95gQgotdBeWG5lld1jG_Wy9g8Y2JxPvE91mWjBjTWGKvA00QVW3PGyiNirQUzqvCPiUCGAkUJ1QlUoVBWEqpKIvSVJrmYSiXb4YXlxonqdVAgNj-6ddIUruKlS44QwlTZeSqlFoiP2knCgSNVR2Fb3FQv4wESapaYYrQaOOBGx3dFMVFE7Gn42IEnREOW11X552ShqG5ZhxMzLiN3vkLV65oxC0VLwiMkR5kYvNR6pF98DQzh-FTQcPI_Y6wGeql-bmn98tYf_N_0p2_ryfqY-fzz89IjdnHQ6Fadyl220F5f-MXprrXnSK-RvrSM6YA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+visceral+fat+area+and+metabolic+syndrome+in+individuals+with+normal+body+weight%3A+insights+from+a+Chinese+health+screening+dataset&rft.jtitle=Lipids+in+health+and+disease&rft.au=Yongbing+Sun&rft.au=Xinbei+Lin&rft.au=Zhi+Zou&rft.au=Yang+Zhou&rft.date=2025-02-18&rft.pub=BMC&rft.eissn=1476-511X&rft.volume=24&rft.issue=1&rft.spage=1&rft.epage=13&rft_id=info:doi/10.1186%2Fs12944-025-02482-0&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_076e2518d7d74bf1bd66bfabe888a60a |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-511X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-511X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-511X&client=summon |